These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12888899)
1. Prognostic relevance of MAPK expression in glioblastoma multiforme. Mawrin C; Diete S; Treuheit T; Kropf S; Vorwerk CK; Boltze C; Kirches E; Firsching R; Dietzmann K Int J Oncol; 2003 Sep; 23(3):641-8. PubMed ID: 12888899 [TBL] [Abstract][Full Text] [Related]
2. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Zhou YH; Tan F; Hess KR; Yung WK Clin Cancer Res; 2003 Aug; 9(9):3369-75. PubMed ID: 12960124 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma. Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172 [TBL] [Abstract][Full Text] [Related]
4. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast. Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969 [TBL] [Abstract][Full Text] [Related]
5. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Halvorsen OJ; Haukaas SA; Akslen LA Clin Cancer Res; 2003 Apr; 9(4):1474-9. PubMed ID: 12684422 [TBL] [Abstract][Full Text] [Related]
6. Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo. Schlegel J; Piontek G; Mennel HD Anticancer Res; 2002; 22(5):2837-40. PubMed ID: 12530006 [TBL] [Abstract][Full Text] [Related]
7. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Pelloski CE; Lin E; Zhang L; Yung WK; Colman H; Liu JL; Woo SY; Heimberger AB; Suki D; Prados M; Chang S; Barker FG; Fuller GN; Aldape KD Clin Cancer Res; 2006 Jul; 12(13):3935-41. PubMed ID: 16818690 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Thomas SM; Coppelli FM; Wells A; Gooding WE; Song J; Kassis J; Drenning SD; Grandis JR Cancer Res; 2003 Sep; 63(17):5629-35. PubMed ID: 14500405 [TBL] [Abstract][Full Text] [Related]
10. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142 [TBL] [Abstract][Full Text] [Related]
11. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival. Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741 [TBL] [Abstract][Full Text] [Related]
12. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292 [TBL] [Abstract][Full Text] [Related]
13. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer. Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Sano T; Lin H; Chen X; Langford LA; Koul D; Bondy ML; Hess KR; Myers JN; Hong YK; Yung WK; Steck PA Cancer Res; 1999 Apr; 59(8):1820-4. PubMed ID: 10213484 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649 [TBL] [Abstract][Full Text] [Related]
17. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663 [TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Heimberger AB; Hlatky R; Suki D; Yang D; Weinberg J; Gilbert M; Sawaya R; Aldape K Clin Cancer Res; 2005 Feb; 11(4):1462-6. PubMed ID: 15746047 [TBL] [Abstract][Full Text] [Related]
19. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. Choe G; Horvath S; Cloughesy TF; Crosby K; Seligson D; Palotie A; Inge L; Smith BL; Sawyers CL; Mischel PS Cancer Res; 2003 Jun; 63(11):2742-6. PubMed ID: 12782577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]